Velomedix

Velomedix is a private, medical device company in Menlo Park, CA created to realize the clinical potential of mild Therapeutic Hypothermia (TH) in patients suffering from acute vascular insults. These include heart attack, cardiac arrest, and ischemic stroke. Therapeutic Hypothermia has been shown to reduce the ischemic and reperfusion effects in these costly and debilitating conditions.

A comprehensive review of the medical literature demonstrates that cooling protects cells at risk, prevents tissue death, and preserves organ function.

Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study. VELOCITY is a prospective, randomized, multi-center study…